{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:49:35Z","timestamp":1761965375514,"version":"3.37.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG048388"],"award-info":[{"award-number":["AG048388"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR061052"],"award-info":[{"award-number":["AR061052"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["DE023105"],"award-info":[{"award-number":["DE023105"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Transformation-related protein 53 (Trp53) is a critical regulator of cell fate determination by controlling cell proliferation and differentiation. Ablation of Trp53 signaling in osteoblast lineages significantly promotes osteogenesis, bone formation, and bone remodeling. However, how Trp53 regulates chondrogenesis and endochondral bone formation is undefined. In this study, we found that Trp53 expression gradually decreased in tibia growth plates during embryonic development in vivo and during chondrogenesis in vitro. By deleting Trp53 in chondrocyte lineage using Col2-Cre transgenic line, we found that loss of Trp53 in chondrocytes significantly increased growth plate growth and bone formation by increasing chondrocyte proliferation, matrix production and maturation, and bone dynamic formation rate. Mechanistically, our data revealed loss of Trp53 significantly promoted TAZ transcriptional activity through inhibition of TAZ phosphorylation and nuclear translocation, whereas its activity was pronouncedly inhibited after forced expression of Trp53. Furthermore, Co-IP data demonstrated that Trp53 associated with TAZ. Moreover, Trp53 decreased the stability of TAZ protein and promoted its degradation through \u03b2-TrCP-mediated ubiquitination. Ablation of TAZ in Col2-Cre;Trp53<jats:sup>f\/f<\/jats:sup>mice rescued the phenotypes of enhanced chondrogenesis and bone formation caused by Trp53 deletion. Collectively, this study revealed that Trp53 modulates chondrogenesis and endochondral ossification through negative regulation of TAZ activity and stability, suggesting that targeting Trp53 signaling may be a potential strategy for fracture healing, heterotopic ossification, arthritis, and other bone diseases.<\/jats:p>","DOI":"10.1038\/s41420-022-01105-2","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T14:04:03Z","timestamp":1657721043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Trp53 controls chondrogenesis and endochondral ossification by negative regulation of TAZ activity and stability via \u03b2-TrCP-mediated ubiquitination"],"prefix":"10.1038","volume":"8","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7126-6901","authenticated-orcid":false,"given":"Shuying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,12]]},"reference":[{"key":"1105_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41421-021-00254-5","volume":"7","author":"Y Li","year":"2021","unstructured":"Li Y, Yang ST, Qin L, Yang SY. TAZ is required for chondrogenesis and skeletal development. Cell Discov. 2021;7:26\u201339.","journal-title":"Cell Discov"},{"key":"1105_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10048-z","volume":"7","author":"Y Jing","year":"2017","unstructured":"Jing Y, Jing J, Ye L, Liu X, Harris SE, Hinton RJ, et al. Chondrogenesis and osteogenesis are one continuous developmental and lineage defined biological process. Sci Rep. 2017;7:10020.","journal-title":"Sci Rep."},{"key":"1105_CR3","doi-asserted-by":"publisher","first-page":"R589","DOI":"10.1016\/S0960-9822(01)00359-1","volume":"11","author":"A White","year":"2001","unstructured":"White A, Wallis G. Endochondral ossification: a delicate balance between growth and mineralisation. Curr Biol. 2001;11:R589\u201391.","journal-title":"Curr Biol"},{"key":"1105_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/1759720X12448454","volume":"4","author":"MB Goldring","year":"2012","unstructured":"Goldring MB. Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis. Ther Adv Musculoskelet Dis. 2012;4:269\u201385.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"1105_CR5","doi-asserted-by":"publisher","first-page":"664168","DOI":"10.3389\/fcell.2021.664168","volume":"9","author":"H Chen","year":"2021","unstructured":"Chen H, Tan XN, Hu S, Liu RQ, Peng LH, Li YM, et al. Molecular mechanisms of chondrocyte proliferation and differentiation. Front Cell Dev Biol. 2021;9:664168.","journal-title":"Front Cell Dev Biol"},{"key":"1105_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.biocel.2007.06.009","volume":"40","author":"EJ Mackie","year":"2008","unstructured":"Mackie EJ, Ahmed YA, Tatarczuch L, Chen KS, Mirams M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell B. 2008;40:46\u201362.","journal-title":"Int J Biochem Cell B"},{"key":"1105_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1172\/JCI34174","volume":"118","author":"MJ Zuscik","year":"2008","unstructured":"Zuscik MJ, Hilton MJ, Zhang X, Chen D, O\u2019Keefe RJ. Regulation of chondrogenesis and chondrocyte differentiation by stress. J Clin Invest. 2008;118:429\u201338.","journal-title":"J Clin Invest"},{"key":"1105_CR8","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.stemcr.2021.01.014","volume":"16","author":"Y Pretemer","year":"2021","unstructured":"Pretemer Y, Kawai S, Nagata S, Nishio M, Watanabe M, Tamaki S, et al. Differentiation of hypertrophic chondrocytes from human iPSCs for the in vitro modeling of chondrodysplasias. Stem Cell Rep. 2021;16:610\u201325.","journal-title":"Stem Cell Rep."},{"key":"1105_CR9","unstructured":"Office of the Surgeon General (US). Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville (MD): Office of the Surgeon General (US); 2004."},{"key":"1105_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1083\/jcb.200507106","volume":"172","author":"XY Wang","year":"2006","unstructured":"Wang XY, Kua HY, Hu YY, Guo K, Zeng Q, Wu Q, et al. p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling. J Cell Biol. 2006;172:115\u201325.","journal-title":"J Cell Biol"},{"key":"1105_CR11","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.3389\/fonc.2020.604124","volume":"10","author":"D Ghatak","year":"2021","unstructured":"Ghatak D, Das Ghosh D, Roychoudhury S. Cancer stemness: p53 at the wheel. Front Oncol. 2021;10:3389\u2013409.","journal-title":"Front Oncol"},{"key":"1105_CR12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41418-020-0590-4","volume":"28","author":"T Velletri","year":"2021","unstructured":"Velletri T, Huang Y, Wang Y, Li Q, Hu M, Xie N, et al. Loss of p53 in mesenchymal stem cells promotes alteration of bone remodeling through negative regulation of osteoprotegerin. Cell Death Differ. 2021;28:156\u201369.","journal-title":"Cell Death Differ"},{"key":"1105_CR13","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/stem.1925","volume":"33","author":"YL He","year":"2015","unstructured":"He YL, de Castro LF, Shin MH, Dubois W, Yang HH, Jiang SL, et al. p53 loss increases the osteogenic differentiation of bone marrow stromal cells. Stem Cells. 2015;33:1304\u201319.","journal-title":"Stem Cells"},{"key":"1105_CR14","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1002\/art.24706","volume":"60","author":"S Hashimoto","year":"2009","unstructured":"Hashimoto S, Nishiyama T, Hayashi S, Fujishiro T, Takebe K, Kanzaki N, et al. Role of p53 in human chondrocyte apoptosis in response to shear strain. Arthritis Rheum-Us. 2009;60:2340\u20139.","journal-title":"Arthritis Rheum-Us"},{"key":"1105_CR15","first-page":"559","volume":"30","author":"R Okazaki","year":"2003","unstructured":"Okazaki R, Sakai A, Ootsuyama A, Sakata T, Nakamura T, Norimura T. Apoptosis and p53 expression in chondrocytes relate to degeneration in articular cartilage of immobilized knee joints. J Rheumatol. 2003;30:559\u201366.","journal-title":"J Rheumatol"},{"key":"1105_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ccr.2009.05.013","volume":"16","author":"L Ho","year":"2009","unstructured":"Ho L, Stojanovski A, Whetstone H, Wei QX, Mau E, Wunder JS, et al. Gli2 and p53 cooperate to regulate IGFBP-3-mediated chondrocyte apoptosis in the progression from benign to malignant cartilage tumors. Cancer Cell. 2009;16:126\u201336.","journal-title":"Cancer Cell"},{"key":"1105_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12026-021-09202-7","volume":"69","author":"M Taghadosi","year":"2021","unstructured":"Taghadosi M, Adib M, Jamshidi A, Mahmoudi M, Farhadi E. The p53 status in rheumatoid arthritis with focus on fibroblast-like synoviocytes. Immunol Res. 2021;69:225\u201338.","journal-title":"Immunol Res"},{"key":"1105_CR18","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1096\/fj.201700872R","volume":"32","author":"CD Kegelman","year":"2018","unstructured":"Kegelman CD, Mason DE, Dawahare JH, Horan DJ, Vigil GD, Howard SS, et al. Skeletal cell YAP and TAZ combinatorially promote bone development. FASEB J. 2018;32:2706\u201321.","journal-title":"FASEB J"},{"key":"1105_CR19","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/ncb3394","volume":"18","author":"Y Tang","year":"2016","unstructured":"Tang Y, Feinberg T, Keller ET, Li XY, Weiss SJ. Snail\/Slug binding interactions with YAP\/TAZ control skeletal stem cell self-renewal and differentiation. Nat Cell Biol. 2016;18:917\u201329.","journal-title":"Nat Cell Biol"},{"key":"1105_CR20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.15252\/embr.201438638","volume":"15","author":"JS Mo","year":"2014","unstructured":"Mo JS, Park HW, Guan KL. The Hippo signaling pathway in stem cell biology and cancer. EMBO Rep. 2014;15:642\u201356.","journal-title":"EMBO Rep."},{"key":"1105_CR21","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3390\/ijms18050961","volume":"18","author":"M Ferraiuolo","year":"2017","unstructured":"Ferraiuolo M, Verduci L, Blandino G, Strano S. Mutant p53 protein and the hippo transducers YAP and TAZ: a critical oncogenic node in human cancers. Int J Mol Sci. 2017;18:961\u201390.","journal-title":"Int J Mol Sci"},{"key":"1105_CR22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ccell.2017.09.010","volume":"32","author":"Y Aylon","year":"2017","unstructured":"Aylon Y, Oren M. Tumor suppression by p53: bring in the Hippo! Cancer Cell. 2017;32:397\u20139.","journal-title":"Cancer Cell"},{"key":"1105_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/cdd.2017.163","volume":"25","author":"N Furth","year":"2018","unstructured":"Furth N, Aylon Y, Oren M. p53 shades of Hippo. Cell Death Differ. 2018;25:81\u201392.","journal-title":"Cell Death Differ"},{"key":"1105_CR24","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1073\/pnas.1610223114","volume":"114","author":"M Shanzer","year":"2017","unstructured":"Shanzer M, Adler J, Ricardo-Lax I, Reuven N, Shaul Y. The nonreceptor tyrosine kinase c-Src attenuates SCF(beta-TrCP) E3-ligase activity abrogating Taz proteasomal degradation. Proc Natl Acad Sci USA. 2017;114:1678\u201383.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1105_CR25","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/carcin\/bgu073","volume":"35","author":"Y Shetzer","year":"2014","unstructured":"Shetzer Y, Solomon H, Koifman G, Molchadsky A, Horesh S, Rotter V. The paradigm of mutant p53-expressing cancer stem cells and drug resistance. Carcinogenesis. 2014;35:1196\u2013208.","journal-title":"Carcinogenesis"},{"key":"1105_CR26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1177\/1947601911410224","volume":"2","author":"BT Spike","year":"2011","unstructured":"Spike BT, Wahl GM. p53, stem cells, and reprogramming: tumor suppression beyond guarding the genome. Genes Cancer. 2011;2:404\u201319.","journal-title":"Genes Cancer"},{"key":"1105_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/jmcb\/mjy087","volume":"11","author":"ME Bowen","year":"2019","unstructured":"Bowen ME, Attardi LD. The role of p53 in developmental syndromes. J Mol Cell Biol. 2019;11:200\u201311.","journal-title":"J Mol Cell Biol"},{"key":"1105_CR28","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1038\/onc.2016.518","volume":"36","author":"M Escoll","year":"2017","unstructured":"Escoll M, Gargini R, Cuadrado A, Anton IM, Wandosell F. Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP\/TAZ. Oncogene. 2017;36:3515\u201327.","journal-title":"Oncogene"},{"key":"1105_CR29","doi-asserted-by":"publisher","first-page":"e28358.","DOI":"10.1371\/journal.pone.0028358","volume":"6","author":"L Taher","year":"2011","unstructured":"Taher L, Collette NM, Murugesh D, Maxwell E, Ovcharenko I, Loots GG. Global gene expression analysis of murine limb development. PLoS ONE. 2011;6:e28358.","journal-title":"PLoS ONE"},{"key":"1105_CR30","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1128\/MCB.00254-07","volume":"27","author":"Y Tian","year":"2007","unstructured":"Tian Y, Kolb R, Hong JH, Carroll J, Li D, You J, et al. TAZ promotes PC2 degradation through a SCF beta-Trcp E3 ligase complex. Mol Cell Biol. 2007;27:6383\u201395.","journal-title":"Mol Cell Biol"},{"key":"1105_CR31","doi-asserted-by":"publisher","first-page":"37159","DOI":"10.1074\/jbc.M110.152942","volume":"285","author":"CY Liu","year":"2010","unstructured":"Liu CY, Zha ZY, Zhou X, Zhang H, Huang W, Zhao D, et al. The Hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF beta-TrCP E3 ligase. J Biol Chem. 2010;285:37159\u201369.","journal-title":"J Biol Chem"},{"key":"1105_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/cdd.2017.174","volume":"25","author":"KD Sullivan","year":"2018","unstructured":"Sullivan KD, Galbraith MD, Andrysik Z, Espinosa JM. Mechanisms of transcriptional regulation by p53. Cell Death Differ. 2018;25:133\u201343.","journal-title":"Cell Death Differ"},{"key":"1105_CR33","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s13238-019-00665-x","volume":"11","author":"X Fu","year":"2020","unstructured":"Fu X, Wu S, Li B, Xu Y, Liu J. Functions of p53 in pluripotent stem cells. Protein Cell. 2020;11:71\u201378.","journal-title":"Protein Cell"},{"key":"1105_CR34","doi-asserted-by":"publisher","first-page":"dev158360.","DOI":"10.1242\/dev.158360","volume":"145","author":"AK Jain","year":"2018","unstructured":"Jain AK, Barton MC. p53: emerging roles in stem cells, development and beyond. Development. 2018;145:dev158360.","journal-title":"Development"},{"key":"1105_CR35","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/carcin\/bgq101","volume":"31","author":"A Molchadsky","year":"2010","unstructured":"Molchadsky A, Rivlin N, Brosh R, Rotter V, Sarig R. p53 is balancing development, differentiation and de-differentiation to assure cancer prevention. Carcinogenesis. 2010;31:1501\u20138.","journal-title":"Carcinogenesis"},{"key":"1105_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0002-9440(10)64356-8","volume":"160","author":"Y Yamanishi","year":"2002","unstructured":"Yamanishi Y, Boyle DL, Pinkoski MJ, Mahboubi A, Lin T, Han Z, et al. Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis. Am J Pathol. 2002;160:123\u201330.","journal-title":"Am J Pathol"},{"key":"1105_CR37","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41586-018-0662-5","volume":"563","author":"K Mizuhashi","year":"2018","unstructured":"Mizuhashi K, Ono W, Matsushita Y, Sakagami N, Takahashi A, Saunders TL, et al. Resting zone of the growth plate houses a unique class of skeletal stem cells. Nature. 2018;563:254\u20138.","journal-title":"Nature"},{"key":"1105_CR38","doi-asserted-by":"crossref","unstructured":"Li X, Yang S, Jing D, Qin L, Zhao H, Yang S. Type II collagen-positive progenitors are major stem cells to control skeleton development and vascular formation. bioRxiv. 2020: 2020.2009.2006.284588.","DOI":"10.1101\/2020.09.06.284588"},{"key":"1105_CR39","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/ncb3067","volume":"16","author":"N Ono","year":"2014","unstructured":"Ono N, Ono W, Nagasawa T, Kronenberg HM. A subset of chondrogenic cells provides early mesenchymal progenitors in growing bones. Nat Cell Biol. 2014;16:1157\u2013U1173.","journal-title":"Nat Cell Biol"},{"key":"1105_CR40","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1101\/gad.1656808","volume":"22","author":"CR Walkley","year":"2008","unstructured":"Walkley CR, Qudsi R, Sankaran VG, Perry JA, Gostissa M, Roth SI, et al. Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev. 2008;22:1662\u201376.","journal-title":"Genes Dev"},{"key":"1105_CR41","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/sctm.20-0424","volume":"10","author":"X Li","year":"2021","unstructured":"Li X, Yang S, Qin L, Yang S. Type II collagen-positive embryonic progenitors are the major contributors to spine and intervertebral disc development and repair. Stem Cells Transl Med. 2021;10:1419\u201332.","journal-title":"Stem Cells Transl Med"},{"key":"1105_CR42","doi-asserted-by":"publisher","first-page":"628","DOI":"10.14336\/AD.2017.0103","volume":"8","author":"JR Aunan","year":"2017","unstructured":"Aunan JR, Cho WC, Soreide K. The biology of aging and cancer: a brief overview of shared and divergent molecular hallmarks. Aging Dis. 2017;8:628\u201342.","journal-title":"Aging Dis"},{"key":"1105_CR43","doi-asserted-by":"publisher","first-page":"1400.","DOI":"10.3390\/cancers13061400","volume":"13","author":"L Berben","year":"2021","unstructured":"Berben L, Floris G, Wildiers H, Hatse S. Cancer and aging: two tightly interconnected biological processes. Cancers. 2021;13:1400.","journal-title":"Cancers"},{"key":"1105_CR44","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1038\/s41388-020-01599-z","volume":"40","author":"Y Li","year":"2021","unstructured":"Li Y, Liu M, Yang ST, Fuller AM, Eisinger-Mathason TSK, Yang SY. RGS12 is a novel tumor suppressor in osteosarcoma that inhibits YAP-TEAD1-Ezrin signaling. Oncogene. 2021;40:2553\u201366.","journal-title":"Oncogene"},{"key":"1105_CR45","doi-asserted-by":"crossref","unstructured":"Li Y, Yang S, Liu Y, Qin L, Yang S. IFT20 governs mesenchymal stem cell fate through positively regulating TGF-\u03b2-Smad2\/3-Glut1 signaling mediated glucose metabolism. bioRxiv. 2022: 2022.2002.2028.482266.","DOI":"10.1101\/2022.02.28.482266"},{"key":"1105_CR46","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1002\/mco2.131","volume":"3","author":"Y Li","year":"2022","unstructured":"Li Y, Yang S, Liu Y, Yang S. Deletion of Trp53 and Rb1 in Ctsk-expressing cells drives osteosarcoma progression by activating glucose metabolism and YAP signaling. MedComm. 2022;3:e131.","journal-title":"MedComm"},{"key":"1105_CR47","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/febs.14026","volume":"284","author":"Y Li","year":"2017","unstructured":"Li Y, Hu N, Yang D, Oxenkrug G, Yang Q. Regulating the balance between the kynurenine and serotonin pathways of tryptophan metabolism. FEBS J. 2017;284:948\u201366.","journal-title":"FEBS J"},{"key":"1105_CR48","doi-asserted-by":"publisher","first-page":"1361.","DOI":"10.3390\/cells11081361","volume":"11","author":"Y Li","year":"2022","unstructured":"Li Y, Yang S, Yang S. Verteporfin inhibits the progression of spontaneous osteosarcoma caused by Trp53 and Rb1 deficiency in Ctsk-expressing cells via impeding Hippo pathway. Cells. 2022;11:1361.","journal-title":"Cells"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-01105-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-01105-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-01105-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T14:34:31Z","timestamp":1700836471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-022-01105-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,12]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1105"],"URL":"https:\/\/doi.org\/10.1038\/s41420-022-01105-2","relation":{},"ISSN":["2058-7716"],"issn-type":[{"type":"electronic","value":"2058-7716"}],"subject":[],"published":{"date-parts":[[2022,7,12]]},"assertion":[{"value":"11 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"317"}}